Venture
Rakuten Medical, Inc.
Latest Form D 2026-04-13- CIK 1595215
- State CA
- Biotechnology
- 16 Form D offerings since 2015-01-23
- Total sold
- $899M
- across 16 offerings
- Rounds
- 16
- Form D offerings since 2015-01-23
- Latest round
- $112M
- 2026-04-13 · 021-580140
- Investors
- 26
- on the latest round
Connected
named in its Form D filingsRound timeline
amount sold · by first filed2026-04-13 · $112M
- 2015-01-23$8.5M021-232786
- 2015-07-30$4.2M021-244731
- 2016-03-10$55.2M021-258981
- 2017-07-21$15.1M021-291296
- 2018-08-23$150M021-319920
- 2019-08-07$100M021-345958
- 2020-07-15$792K021-371076
- 2021-01-05$90M021-385234
- 2021-01-14$15M021-386374
- 2021-07-29$166M021-408174
- 2022-07-07$2.2M021-451442
- 2022-12-28$70M021-468953
- 2023-09-01$105M021-491218
- 2024-03-28$4.2M021-508978
- 2025-02-05$1.9M021-537424
- 2026-04-13$112M021-580140
Hover a dot or row, or tab through the dots · bars scaled to the largest round ($166M)
Form D offerings
One line per offering, amendments folded in, newest first
| File | First filed | Latest | Sought | Sold | Investors | Exemptions |
|---|---|---|---|---|---|---|
| 021-580140 | First filed2026-04-13 | Latest2026-04-13 | Sought$117M | Sold$112M | Investors26 | Exemptions506(b) |
| 021-537424 | First filed2025-02-05 | Latest2025-05-07 | Sought$1.9M | Sold$1.9M | Investors14 | Exemptions506(b) |
| 021-508978 | First filed2024-03-28 | Latest2024-03-28 | Sought$4.2M | Sold$4.2M | Investors15 | Exemptions506(b) |
| 021-491218 | First filed2023-09-01 | Latest2023-09-01 | Sought$124M | Sold$105M | Investors15 | Exemptions506(b) |
| 021-468953 | First filed2022-12-28 | Latest2022-12-28 | Sought$90M | Sold$70M | Investors4 | Exemptions506(b) |
| 021-451442 | First filed2022-07-07 | Latest2023-10-04 | Sought$2.2M | Sold$2.2M | Investors20 | Exemptions506(b) |
| 021-408174 | First filed2021-07-29 | Latest2021-07-29 | Sought$291M | Sold$166M | Investors10 | Exemptions506(b) |
| 021-386374 | First filed2021-01-14 | Latest2021-01-14 | Sought$15M | Sold$15M | Investors1 | Exemptions506(b) |
| 021-385234 | First filed2021-01-05 | Latest2021-01-05 | Sought$90M | Sold$90M | Investors6 | Exemptions506(b) |
| 021-371076 | First filed2020-07-15 | Latest2020-07-15 | Sought$792K | Sold$792K | Investors1 | Exemptions506(b) |
| 021-345958 | First filed2019-08-07 | Latest2019-08-07 | Sought$100M | Sold$100M | Investors1 | Exemptions506(b) |
| 021-319920 | First filed2018-08-23 | Latest2018-11-07 | Sought$350M | Sold$150M | Investors4 | Exemptions506(b) |
| 021-291296 | First filed2017-07-21 | Latest2017-07-21 | Sought$19M | Sold$15.1M | Investors45 | Exemptions506(b) |
| 021-258981 | First filed2016-03-10 | Latest2016-10-05 | Sought$56M | Sold$55.2M | Investors8 | Exemptions506(b) |
| 021-244731 | First filed2015-07-30 | Latest2015-07-30 | Sought$4.2M | Sold$4.2M | Investors3 | Exemptions506(b) |
| 021-232786 | First filed2015-01-23 | Latest2015-01-23 | Sought$8.5M | Sold$8.5M | Investors8 | Exemptions506(b) |
Who backs Rakuten Medical, Inc., inferred from co-filings, and every Form D as filedSee plans
People
Named in Item 3 of its latest Form D, filed 2026-04-13
| Name | Relationship |
|---|---|
| Maeda Minami | RelationshipExecutive Officer |
| David Chao | RelationshipDirector |
| Mazen Darwazah | RelationshipDirector |
| Miguel Garcia-Guzman | RelationshipDirector |
| Kentaro Hyakuno | RelationshipDirector |
| Hiroshi Mikitani | RelationshipExecutive Officer, Director |
| Hiroshi Mori | RelationshipDirector |
| Nitin Nohria | RelationshipDirector |
| Eiichi Kaga | RelationshipDirector |
| Tiffany Piecewicz | RelationshipExecutive Officer |
| Abhijit Bhatia | RelationshipExecutive Officer |
| Carlos Garcia | RelationshipExecutive Officer |
| Toshiaki Suzuki | RelationshipExecutive Officer |
| Hiroyuki Kodama | RelationshipExecutive Officer |
| Suzane San | RelationshipExecutive Officer |
Sales compensation
Named in Item 12 of its Form D filings
| Recipient | CRD | Broker-dealer | Offerings |
|---|---|---|---|
| Momentum Capital Markets, LLC | CRD300288 | Broker-dealer— | Offerings1 |
| TAP Securities LLC | CRD151593 | Broker-dealer— | Offerings1 |
Facts
As its latest Form D states them
- Industry
- Biotechnology
- State
- California (CA)
- Exemptions
- Rule 506(b)
- First filed
- 2015-01-23
- Latest filing
- 2026-04-13
Who backs Rakuten Medical, Inc.
Form D names a startup's officers and directors, not its investors. The dashboard infers them — the venture funds whose own filings and people overlap this company's rounds — and lays every Form D and amendment it filed beside the totals above.
- Inferred investors — the funds and firms behind it, from co-filings and shared people
- Every Form D and amendment as filed, with what each one stated
- Its rounds in sequence: the gap between them and whether they grew
- Everyone its filings name, linked to their other companies, with its addresses and phone numbers
Part of the Venture plan — $140/mo at launch pricing ($350 list)
See plansExternal link: SEC Filings ↗